Unclaimed brand
Bringing life into balance Dedicated to rapidly and directly disrupting the central mechanism of Graves’ disease and TED Patients with Graves’ disease and
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#EBB254
Ronchi
235, 178, 84
37, 79, 63
0, 24, 64, 8
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#330968
Windsor
51, 9, 104
267, 84, 22
51, 91, 0, 59
VYNE Therapeutics is an innovative brand dedicated to tackling complex therapeutic challenges. With a commitment to questioning conventional assumptions and seeking better solutions, VYNE Therapeutics aims to provide innovative products that make a real difference in patients' lives. Their pipeline includes the groundbreaking InhiBET™ BET Inhibitor Platform, as well as specific products like VYN201, VYN202, and FMX114.
VYNE Therapeutics is actively working towards developing these innovative treatments for patients. Investors and media outlets can stay updated on the brand's progress through their stock information, press releases, and events. Job seekers can be part of the brand's next chapter by exploring career opportunities.
VYNE Therapeutics is rooted in innovation and is dedicated to making a positive impact in the realm of therapeutics
Company type
Public Company
Year founded
2003
Company size
11-50 employees
TSH receptor monoclonal antibodies
Graves’ disease therapeutics
Thyroid eye disease therapeutics
Autoimmune thyroid disease drug development
